BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22848561)

  • 1. Bisphenol A binds to the local anesthetic receptor site to block the human cardiac sodium channel.
    O'Reilly AO; Eberhardt E; Weidner C; Alzheimer C; Wallace BA; Lampert A
    PLoS One; 2012; 7(7):e41667. PubMed ID: 22848561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenylamine block of Nav1.5 channel is mediated via a receptor distinct from that of local anesthetics.
    Mujtaba MG; Wang SY; Wang GK
    Mol Pharmacol; 2002 Aug; 62(2):415-22. PubMed ID: 12130695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel.
    Nguyen PT; DeMarco KR; Vorobyov I; Clancy CE; Yarov-Yarovoy V
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2945-2954. PubMed ID: 30728299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na⁺ channel, Na(v)1.5.
    Schulze V; Stoetzer C; O'Reilly AO; Eberhardt E; Foadi N; Ahrens J; Wegner F; Lampert A; de la Roche J; Leffler A
    Br J Pharmacol; 2014 Jan; 171(2):427-37. PubMed ID: 24117196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine-401 as a batrachotoxin- and local anesthetic-sensing residue in the human cardiac Na+ channel.
    Wang SY; Tikhonov DB; Zhorov BS; Mitchell J; Wang GK
    Pflugers Arch; 2007 May; 454(2):277-87. PubMed ID: 17205354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural modeling of human cardiac sodium channel pore domain.
    Ji X; Xiao Y; Liu S
    J Biomol Struct Dyn; 2018 Jul; 36(9):2268-2278. PubMed ID: 28682144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of the inhibition of the fast inactivation of voltage-gated sodium channel Nav1.5 by tarantula toxin Jingzhaotoxin-II.
    Huang Y; Zhou X; Tang C; Zhang Y; Tao H; Chen P; Liu Z
    Peptides; 2015 Jun; 68():175-82. PubMed ID: 25817910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the human Na
    Ahmed M; Jalily Hasani H; Ganesan A; Houghton M; Barakat K
    Drug Des Devel Ther; 2017; 11():2301-2324. PubMed ID: 28831242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
    Wang GK; Wang SY
    Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local-anesthetic like inhibition of the cardiac sodium channel Nav1.5 α-subunit by 5-HT3 receptor antagonists.
    Van't Klooster MP; Foadi N; Hage A; Stoetzer C; Wegner F; Eberhardt M; Leffler A
    Eur J Pharmacol; 2016 Oct; 789():119-126. PubMed ID: 27401036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of hNaV1.7.
    Thomas-Tran R; Du Bois J
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5856-61. PubMed ID: 27162340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials.
    Desaphy JF; Carbonara R; Costanza T; Lentini G; Cavalluzzi MM; Bruno C; Franchini C; Camerino DC
    Mol Pharmacol; 2013 Feb; 83(2):406-15. PubMed ID: 23175529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation.
    Zhu W; Mazzanti A; Voelker TL; Hou P; Moreno JD; Angsutararux P; Naegle KM; Priori SG; Silva JR
    Circ Res; 2019 Feb; 124(4):539-552. PubMed ID: 30566038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.
    Qu Y; Rogers J; Tanada T; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11839-43. PubMed ID: 8524860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the interaction site for the tarantula toxin hainantoxin-IV (β-TRTX-Hn2a) in the voltage sensor module of domain II of voltage-gated sodium channels.
    Cai T; Luo J; Meng E; Ding J; Liang S; Wang S; Liu Z
    Peptides; 2015 Jun; 68():148-56. PubMed ID: 25218973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized Fullerene Targeting Human Voltage-Gated Sodium Channel, hNa
    Hilder TA; Robinson A; Chung SH
    ACS Chem Neurosci; 2017 Aug; 8(8):1747-1755. PubMed ID: 28586206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
    Wang Y; Mi J; Lu K; Lu Y; Wang K
    PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.
    Desaphy JF; Dipalma A; Costanza T; Bruno C; Lentini G; Franchini C; George A; Conte Camerino D
    Br J Pharmacol; 2010 Jul; 160(6):1521-33. PubMed ID: 20590641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.
    Poulin H; Bruhova I; Timour Q; Theriault O; Beaulieu JM; Frassati D; Chahine M
    Mol Pharmacol; 2014 Oct; 86(4):378-89. PubMed ID: 25028482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting sodium channel activity using calcium flux: pharmacological promiscuity of cardiac Nav1.5.
    Zhang H; Zou B; Du F; Xu K; Li M
    Mol Pharmacol; 2015 Feb; 87(2):207-17. PubMed ID: 25422141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.